Loading…

 

Innovation in Next Generation Sequencing

Making Genomics Available and Affordable for Everyone

Learn More

Evolving Health Testing and Prognosis

A cooperative-based clinical laboratory using state-of-the-art innovation in Next Generation Sequencing and machine/deep learning

A new way to internalize or outsource your genomic profiling for cancer

There are two ways to work together

a. Outsource Testing and b. Internalize Testing

First, you may be asking - What is a Co-op? A co-op is when people join together as a community to share resources By sharing resources, the costs of ownership is shared but you get all of the benefits of owning this equipment yourself. It’s there when you need it as much as you need it This allows for economies of scale to take place driving down the costs while keeping the quality high Being a member you also have a say with the other members of the co-op on the direction it takes and helps you get the products you need for your business You also have additional benefits that come along with it like deep expertise, a huge library of resources, an easy billing structure and more.

Learn more about the GTC co-op model

State-of-the-art Innovation

Machine/deep Learning meets Next Generation Sequencing

  • Who are we? Genomic Testing Cooperative (GTC) is creating a genomic testing lab combining next-gen sequencing (NGS) with AI that will disrupt the current model.
  • Why? Genomic testing is expensive and risky for smaller labs because competing with major NGS labs is challenging to get scale and payment.
  • How? Using a co-op model to reduce sales and service costs – the biggest impediment to profitability by sharing resources.
  • What makes it different? We use the latest advances in NGS combined with AI to compile the latest information to treat patients. The Co-op model produces big data for AI analysis and of value for Pharma and insurance companies.
%
PRECISION
GENES
TESTS
%
LOWER COST

OFFERING NEXT-GEN TESTS FOR ALL

Available and Affordable for Everyone

-Breaking News-

FDA Approves* Vitrakvi (larotrectinib), a targeted therapy for patients with solid tumors harboring an NTRK gene fusion, regardless of tumor type

Genomic Testing Cooperative (GTC) offers a comprehensive next-generation sequencing (NGS) Solid Tumor Fusion/ Expression profile specifically testing for fusions in NTRK1, NTRK2, and NTRK3 at an affordable price. 

Contact us today at (949) 540-9421 to order and learn more about our NGS offering. Get Results in 7 to 10 days.  

*Read about the approval  on Reuters

Pain-Free

High End Genomic Testing

Features of Our Services

Advanced Genomic Testing

Preview Our Requisitions

Test Requisition Preview

GTC Solid Tumor Profile Plus

Access Our Tests

Click button below

Hematology Profile Plus

OUR SCIENCE

FEATURED BLOG POSTS AND PUBLICATIONS

Loading…

Get More Than A Preview

LEARN HOW GENOMICS CAN HELP YOUR LIFE

Subscribe to our verified users' list and get access to premium content

  • Download our requisitions
  • See Sample Tests
  • Get the Latest News
  • Get Notified on upcoming events

 

Next-Gen Sequencing  made Available and Affordable 

Next-Gen Sequencing Revolutionary Methods never used before. NGS or Next-generation sequencing has changed medicine in the past decade in ways most people couldn’t imagine. It has allowed a rapid evolution to the field of precision medicine with new drugs with being approved regularly.

Evolving Health Testing and Prognosis

A cooperative-based clinical laboratory using state-of-the-art innovation in NGS Genomics and machine/deep learning.

We work together

A Cooperation Model of Bringing new solutions. Simply put a co-op means we all work together as a team to make things better. In the case of the Genomic Testing Cooperative, it means that our lab works with other labs, physicians and patients to improve the communities access to cutting-edge healthcare at an affordable price.

Artificial Intelligence Machine Learning Bringing computer science to laboratories

Our AI helps us sort through curate large sets of data so we can quickly make sense of genomic alterations and assess their impact on patient prognosis, diagnosis and help predict their response to therapy. We use machine learning to review these alterations and track their frequency allowing us to gain new insights into cancer. 

What is innovative about GTC 

  • Genomic Testing Cooperative (GTC) is creating a genomic testing lab combining next-gen sequencing (NGS) with AI that will disrupt the current model.
  • Genomic testing is expensive and risky for smaller labs because competing with major NGS labs is challenging to get scale and payment.
  • Using a co-op model to reduce sales and service costs – the biggest impediment to profitability by sharing resources.
  • We use the latest advances in NGS combined with AI to compile the latest information to treat patients.
  • The Co-op model produces big data for AI analysis and of value for Pharma and insurance companies.

Complete molecular profiling including comprehensive interpretation, therapeutic options, and clinical trials are offered to co-op member laboratories at an affordable price.

.